Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials

BACKGROUND: Objectives were to compare systemic mould-active vs fluconazole prophylaxis in cancer patients receiving chemotherapy or haematopoietic stem cell transplantation (HSCT). METHODS: We searched OVID MEDLINE and the Cochrane Central Register of Controlled Trials (1948-August 2011) and EMBASE...

Descripción completa

Detalles Bibliográficos
Autores principales: Ethier, M C, Science, M, Beyene, J, Briel, M, Lehrnbecher, T, Sung, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349180/
https://www.ncbi.nlm.nih.gov/pubmed/22568999
http://dx.doi.org/10.1038/bjc.2012.147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349180/
https://www.ncbi.nlm.nih.gov/pubmed/22568999
http://dx.doi.org/10.1038/bjc.2012.147

Ejemplares similares